M&A
confidence high
sentiment positive
materiality 0.75
ShiftPixy agrees to acquire Neozene for $16.5M in cash and stock
ShiftPixy, Inc.
- Total consideration $16.5M: $5.5M cash at close, $5.5M in stock at 9 months, $5.5M in stock at 18 months contingent on 90% of pre-closing gross revenue.
- Target (Neozene) has annual revenue run rate $58M, EBITDA $3.4M, 94 commercial accounts, and over 35,800 worksite employees.
- Acquisition expected to close in Q2 2024, subject to customary conditions and ShiftPixy securing financing.
- CEO Scott Absher describes this as the first in a series of acquisitions to expand market presence in the Gig Economy.